Engineers Gate Manager LP Agios Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

$5.55 Billion
Q1 2025

A detailed history of Engineers Gate Manager LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 22,717 shares of AGIO stock, worth $819,402. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,717

Previous 60,205 62.27%

Holding current value

$819,402

Previous $1.98 Million 66.38%

% of portfolio

0.01%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$29.3 - $35.9 $1.1 Million - $1.35 Million	-37,488 Reduced 62.27%	22,717 $665,000
Q4 2024 Feb 14, 2025	BUY	$32.86 - $61.64 $1.19 Million - $2.23 Million	36,192 Added 150.72%	60,205 $1.98 Million
Q3 2024 Nov 14, 2024	SELL	$41.19 - $49.72 $73,853 - $89,147	-1,793 Reduced 6.95%	24,013 $1.07 Million
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $296,548 - $525,606	-10,764 Reduced 29.43%	25,806 $1.11 Million
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $255,498 - $417,163	11,984 Added 48.74%	36,570 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $490,982 - $603,094	24,586 New	24,586 $547,000
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $695,997 - $965,962	-16,603 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $12,025 - $14,153	-231 Reduced 1.37%	16,603 $915,000
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $439,380 - $571,205	9,934 Added 143.97%	16,834 $869,000
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $305,465 - $428,074	-9,198 Reduced 57.14%	6,900 $299,000
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $368,708 - $608,853	10,886 Added 208.86%	16,098 $563,000
Q2 2020 Aug 17, 2020	BUY	$34.45 - $53.48 $179,553 - $278,737	5,212 New	5,212 $279,000
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $573,033 - $978,265	-18,180 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $118,244 - $198,869	3,931 Added 27.59%	18,180 $868,000
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $461,667 - $706,465	14,249 New	14,249 $462,000
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $189,297 - $279,210	-4,100 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $188,272 - $277,447	4,100 New	4,100 $277,000

Others Institutions Holding AGIO

# of Institutions

237

Shares Held

60.1M

Call Options Held

323K

Put Options Held

367K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.98B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Agios Pharmaceuticals, Inc. Transaction History